Atlas Trials

Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia

Clinical trial NCT00141141 · COMPLETED

Trial details

NCT number
NCT00141141
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2004-01-01
Enrollment
383

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.